GUJARAT TERCE LABORATORIES LTD
GUJTERC (BSE 524314) · ISIN INE499G01013 · Pharmaceuticals · Est. 1985 · listed 1993 · website
Not on any surveillance list
Next: Board meeting: financial results on 5 November 2026.
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹9.73 cr | ₹1.3 cr | ₹24.55 cr |
| 30 Sep 2025 standalone | ₹7.84 cr | ₹0.59 cr | ₹24.43 cr |
| 31 Mar 2025 standalone | ₹6.48 cr | ₹0.94 cr | ₹22.83 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 40.03% | — | — | 59.97% |
Latest filings
- Detailed disclosure is attached 21 August 2026 · BSE
- Detailed disclosure is attached. 21 August 2026 · BSE
- Detailed disclosure is attached. 7 August 2026 · BSE
- Detailed disclosure is attached. 7 August 2026 · BSE
- 41st AGM of the shareholders of Gujarat Terce Laboratories Limited will be held on 21st August, 2026 at 12:00 noon through Video Conferencing or any other Audio-Visual Means facility 28 July 2026 · BSE
Other companies in Pharmaceuticals
- Sun Pharmaceutical Industries Limited
- Lupin Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Mankind Pharma Limited
- Aurobindo Pharma Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.